Andrew Derodra has been appointed chief financial officer and executive director of Skyepharma PLC. Mr. Derodra joins the company from Tate & Lyle, where he has served as group vice president Finance & Control since 2011. He also spent 23 years working in senior finance roles within five FTSE100 groups including SABMiller, Diageo, British Airways and Reed Elsevier.
Peter Grant, chief executive officer of Skyepharma, said, “This is an excellent appointment for Skyepharma and Andrew joins the company at an important point in our development. Andrew brings a broad range of business experience and I look forward to working with him as we leverage our strong platform for future growth and continue to create value for our shareholders.”